tiprankstipranks
Summit Therapeutics PLC (SMMT)
:SMMT
US Market

Summit Therapeutics (SMMT) Income Statement

Compare
1,254 Followers

Summit Therapeutics Income Statement

Last quarter (Q3 2024), Summit Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Summit Therapeutics's net income was $-56.25M. See Summit Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 704.29K$ 1.81M$ 860.00K-
Gross Profit
$ -2.05M$ -1.81M$ 1.81M$ 860.00K-
Operating Expenses
$ 87.69M$ 64.28M$ 88.00M$ 53.19M$ 42.00M
Depreciation and Amortization
$ 90.74M$ 2.51M$ 2.46M$ 2.00M-
EBITDA
$ 1.00M$ -52.63M$ -62.74M$ -37.13M$ -16.80M
Operating Income
$ -89.74M$ -72.09M$ -86.19M$ -53.19M$ -42.76M
Other Income/Expenses
$ -526.14M$ -19.15M$ -24.87M$ -14.01M-
Pretax Income
$ -615.87M$ -78.78M$ -88.60M$ -52.91M$ -28.41M
Net Income
$ -614.93M$ -74.38M$ -86.15M$ -52.70M$ -23.88M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.99$ -0.38$ -0.93$ -0.76$ -0.15
Diluted EPS
$ -0.99$ -0.38$ -0.93$ -0.76$ -0.15
Weighted Average Shares Outstanding
619.65M 193.34M 92.24M 69.52M 164.15M
Weighted Average Shares Outstanding (Diluted)
619.65M 193.34M 92.24M 69.52M 164.15M
Currency in USD

Summit Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis